VTE More Measure
Venus thromboembolism (VTE) is a condition that includes both pulmonary embolism (PE) and deep vein thrombosis. DVT occurs when blood clots in deep veins normally in the pelvic veins or in the legs. However, VTE is common in many regions and it is a dreadful condition. Notably, patients suffering from VTE have a 35% to 65% chance of dying from it. It is important to research on Venus thromboembolism (VTE) because as the third most common cardiovascular disease, it is a leading cause of mortality and mobility worldwide. Several risk factors are associated with VTE such as; increase in age, orthopaedic surgery, and immobility. In addition, VTE is the result of slowing of the blood flow (stasis), damage of endothelial lining, and hypercoagulability (Amin, 2008, p. 234).
As a multifactorial disease that results from the combination of various risk factors both acquired and inherited, recent studies show that younger people are more at risk compared to older people. Thrombophilia testing has been on the increase lately in a number of indications including patients. The biggest issue with this outcome is that it is not clear whether testing of thrombophilia will help solve the scientific management of issues concerning patients (Joint, 2010, p. 23).
It is of paramount importance to not coherently that for a number of reasons, testing for thrombophilia is very common among young patients. For instance, patients with thromboses or with current episodes of VTE are found to test for thrombophilia quite often. On the other hand, patients with recognized risks factors such as trauma, pregnancy, surgery, and puer-perium, are less likely to have a recurrence of VTE. However, based on the presence of thrombophilia, predictions of its occurrence are yet to be explored. In the surgery of VTE, presence of clinical risk factors such as; hypertension, obesity, dyslipidemia, smoking, and obesity should be integrated. It is suggest that the best approach for VTE is by evaluating all patients for primary prophylaxis to identify unidentified conditions because hospitalized patients could die from pulmonary embolism (PE) after developing asymptomatic deep vein thrombosis (Deitelzweig, 2011, p. 562).
Recent studies show that in the 15-35 and 15-48 age groups, mortality rate was high for patients with VTE. Notably, incidences of thrombosis mainly depend on age as it is a common affliction among the elderly. However, risk factors that are required to cause VTE invariably occur when a number of risk factors of acquiring thrombosis occur. Therefore, as one ages, the number of risk factors required to cause thrombosis decrease. As a multifactorial disease that results from the combination of various risk factors both acquired and inherited, recent studies show that younger people are more at risk compared to older people. It is estimated that close to 800,000 Americans develop DVT every year. Among these persons, 450,000 develop PE with 30% PEs being lethal. This study has focused on the recent developments of VTE (October, 2010, p. 222). Subsequently, it emerges that VTE is common among young people as compared to the elderly. Young patients suffering from VTE have a 35% to 65% chance of dying from it. It is important to research on Venus thromboembolism (VTE) because as the third most common cardiovascular disease, it is a leading cause of mortality and mobility worldwide. However, through intervention such as clinical tests, VTE can be controlled and patients can recover from it.
References
Amin, A. N., & Deitelzweig, S. B. (2009). Optimizing the prevention of venous thromboembolism: recent quality initiatives and strategies to drive improvement. Joint Commission Journal on Quality and Patient Safety, 35(11), 558-564.
Deitelzweig, S. B., Johnson, B. H., Lin, J., & Schulman, K. L. (2011). Prevalence of clinical venous thromboembolism in the USA: current trends and future projections. American journal of hematology, 86(2), 217-220.
Joint Commission. (2010). Performance Measurement Initiatives. Venous Thromboembolism (VTE) Core Measures Set-Last Updated 4/2009.
October, A. 2, 2010]; Surgical Care Improvement Project VTE Core Measures Set.
